You can now follow the latest news for free through our Facebook page
Click here to subscribe
Washington: Nine heads of companies developing vaccines against Covid-19 signed a joint declaration Tuesday to commit to the highest degree of scientific rigor, in an implicit response to concerns expressed in the United States about pressure that Donald Trump might exert to authorize the circulation of a vaccine before the presidential elections.
The CEOs of AstraZeneca, Bayontec, GlaxoSmithKline, Johnson & Johnson, Merck Sharp & Dome, Moderna, Novavax, Pfizer and Sanofi declared in a joint statement: “We, the undersigned biopharmaceutical companies, wish to reaffirm our firm commitment to developing and testing potential vaccines against COVID-19 in accordance with high ethical standards and principles. Rigorous scientific. ”
These companies pledged in particular “not to apply for a license, or to request an urgent license, except after proving the safety and efficacy of the vaccine in the context of a Phase 3 clinical trial designed and implemented in order to meet the requirements set by regulatory authorities such as the US Food and Drug Administration.”
There are concerns about the US Food and Drug Administration raised by many experts and former health officials in the United States, after it allowed an emergency, despite the lack of strict evidence, to use two drugs against Covid-19, hydroxychloroquine (permission was later revoked) and blood plasma from Recovered patients, both promoted by Donald Trump.
In recent days, the Democratic nominee to the White House, Joe Biden, accused Donald Trump of “undermining the public’s confidence” by talking about the possibility of a vaccine being introduced before the November 3 election.
For his part, the head of the US Food and Drug Administration has ensured that a purely scientific approach is taken to judge the effectiveness of any vaccine.
In the United States, committees of independent experts are overseeing clinical trials that have made good progress on the Moderna and Pfizer vaccines, for which health authorities want to adopt a distribution system for them by November 1.
In theory, the Food and Drug Administration relies on these independent committees, and on vaccine manufacturers, who must apply for marketing authorization.
Anthony Fauci, director of the National Institute of Infectious Diseases, does not expect results of clinical trials to be released before the last two months of the year.
Moncef Al-Salawi, the chief scientist overseeing the Warp Speed process run by the White House to find vaccines, told American Radio that it is “highly unlikely, but not impossible” for the experiments to yield results before the elections.